DE602004025583D1 - Polysaccharidderivate mit antithrombotischer wirkung im plasma - Google Patents

Polysaccharidderivate mit antithrombotischer wirkung im plasma

Info

Publication number
DE602004025583D1
DE602004025583D1 DE602004025583T DE602004025583T DE602004025583D1 DE 602004025583 D1 DE602004025583 D1 DE 602004025583D1 DE 602004025583 T DE602004025583 T DE 602004025583T DE 602004025583 T DE602004025583 T DE 602004025583T DE 602004025583 D1 DE602004025583 D1 DE 602004025583D1
Authority
DE
Germany
Prior art keywords
sulphation
partial
plasma
acetylheparosan
polysaccharide derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004025583T
Other languages
German (de)
English (en)
Inventor
Marco Manoni
Liana Salsini
Jacopo Chini
Giovanni Cipolletti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inalco SpA
Original Assignee
Inalco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inalco SpA filed Critical Inalco SpA
Publication of DE602004025583D1 publication Critical patent/DE602004025583D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/848Escherichia
    • Y10S435/849Escherichia coli

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
DE602004025583T 2003-08-06 2004-07-07 Polysaccharidderivate mit antithrombotischer wirkung im plasma Expired - Fee Related DE602004025583D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001618A ITMI20031618A1 (it) 2003-08-06 2003-08-06 Derivati polisaccaridici dotati di alta attivita'
PCT/EP2004/051391 WO2005014656A1 (en) 2003-08-06 2004-07-07 Polysaccharides derivatives with high antithrombotic activity in plasma

Publications (1)

Publication Number Publication Date
DE602004025583D1 true DE602004025583D1 (de) 2010-04-01

Family

ID=34131211

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004025583T Expired - Fee Related DE602004025583D1 (de) 2003-08-06 2004-07-07 Polysaccharidderivate mit antithrombotischer wirkung im plasma

Country Status (18)

Country Link
US (1) US7687249B2 (https=)
EP (1) EP1654288B9 (https=)
JP (1) JP2007501305A (https=)
KR (1) KR20060063933A (https=)
CN (1) CN1832966A (https=)
AT (1) ATE458009T1 (https=)
AU (1) AU2004262584A1 (https=)
BR (1) BRPI0413346A (https=)
CA (1) CA2534709A1 (https=)
DE (1) DE602004025583D1 (https=)
DK (1) DK1654288T3 (https=)
ES (1) ES2341249T3 (https=)
IL (1) IL173482A0 (https=)
IT (1) ITMI20031618A1 (https=)
MX (1) MXPA06001511A (https=)
RU (1) RU2361881C2 (https=)
WO (1) WO2005014656A1 (https=)
ZA (1) ZA200601643B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006316039B2 (en) * 2005-11-21 2011-08-18 Ge Healthcare Bio-Sciences Ab A method of chromatography using semi-synthetic heparin ligands
US9498494B2 (en) 2008-09-11 2016-11-22 Agency For Science, Technology And Research Glycosaminoglycans
GB0818255D0 (en) 2008-10-06 2008-11-12 Agency Science Tech & Res Isolation and identification of glycosaminoglycans
CN101698838B (zh) * 2008-12-26 2012-05-23 北京大学 尿苷二磷酸葡萄糖醛酸异构酶及其编码基因与应用
ITMI20091445A1 (it) * 2009-08-07 2011-02-08 Inalco S P A A Socio Unico Derivati semi-sintetici del polisaccaride k5 per la prevenzione ed il trattamento del danno tissutale associato a ischemia e/o riperfusione
KR101515892B1 (ko) * 2009-09-01 2015-05-04 렌슬러 폴리테크닉 인스티튜트 K5 헤파로산 발효 및 정제
US9012168B2 (en) 2010-07-29 2015-04-21 Shire Human Genetic Therapies, Inc. Assays for detection of glycosaminoglycans
EP2809796A4 (en) * 2012-02-01 2016-08-17 Shire Human Genetic Therapies TESTS FOR THE DETECTION OF GLYCOSAMINOGLYCANES
CN102796723A (zh) * 2012-09-11 2012-11-28 深圳市海普瑞药业股份有限公司 肝素酶i的固定化方法
CN102888390B (zh) * 2012-10-30 2014-09-03 深圳市海普瑞药业股份有限公司 肝素酶ⅲ的固定化方法
CN103059165B (zh) * 2012-12-26 2015-04-29 安徽丰原药业股份有限公司 一种多糖酰化物及其制备方法
HUE053923T2 (hu) 2015-12-28 2021-08-30 Ajinomoto Kk Eljárás antikoaguláns aktivitással rendelkezõ heparán-szulfát elõállítására
JP6225321B1 (ja) 2016-08-31 2017-11-08 王子ホールディングス株式会社 ポリ硫酸ペントサンの製造方法
EP3677587A4 (en) 2016-08-31 2021-04-14 Oji Holdings Corporation XYLOOLIGOSACCHARIDE ACID, AND METHOD FOR MANUFACTURING THE SAME
JP6281659B1 (ja) 2017-02-28 2018-02-21 王子ホールディングス株式会社 ポリ硫酸ペントサン、医薬組成物及び抗凝固剤
CA3065747C (en) 2017-05-31 2024-10-01 Oji Holdings Corporation MOISTURIZING COMPOSITION CONTAINING PENTOSANNE POLYSULFATE
PL3683242T3 (pl) 2017-09-12 2025-03-03 Oji Holdings Corporation Polisiarczan pentozanu i sposób wytwarzania polisiarczanu pentozanu
KR102533822B1 (ko) 2017-12-20 2023-05-17 오지 홀딩스 가부시키가이샤 폴리황산펜토산 및 폴리황산펜토산을 포함하는 의약

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1214609B (it) * 1985-05-17 1990-01-18 Opocrin Spa Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
FR2669932B1 (fr) 1990-12-03 1994-07-01 Sanofi Sa Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.
IT1271057B (it) 1994-11-04 1997-05-26 Inalco Spa Polisaccaridi aventi un elevato contenuto di acido iduronico
IT1282994B1 (it) * 1996-05-10 1998-04-03 Inalco Spa Derivati del polisaccaride k5 aventi elevata attivita' anticoagulante
IT1290814B1 (it) 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
SE9701454D0 (sv) 1997-04-18 1997-04-18 Ulf Lindahl new DNA sequences and a process for enzyme manufacture
US20020062019A1 (en) 2000-03-30 2002-05-23 Pasqua Oreste Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
IT1318432B1 (it) * 2000-03-30 2003-08-25 Inalco Spa Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro
ITMI20011633A1 (it) * 2001-07-27 2003-01-27 San Raffaele Centro Fond Uso di polisaccaridi batterici supersolfatati inibitori dell'hiv
CN1675249A (zh) * 2002-06-18 2005-09-28 格利考斯2000有限公司 N-酰基-(表)k5-胺-o-硫酸盐衍生物及其产品的制备方法

Also Published As

Publication number Publication date
EP1654288A1 (en) 2006-05-10
RU2006106790A (ru) 2007-09-20
BRPI0413346A (pt) 2006-10-10
MXPA06001511A (es) 2006-05-15
EP1654288B1 (en) 2010-02-17
WO2005014656A1 (en) 2005-02-17
CN1832966A (zh) 2006-09-13
EP1654288B9 (en) 2010-06-23
US7687249B2 (en) 2010-03-30
ZA200601643B (en) 2007-05-30
JP2007501305A (ja) 2007-01-25
ATE458009T1 (de) 2010-03-15
US20070042993A1 (en) 2007-02-22
ITMI20031618A1 (it) 2005-02-07
ES2341249T3 (es) 2010-06-17
RU2361881C2 (ru) 2009-07-20
DK1654288T3 (da) 2010-09-20
IL173482A0 (en) 2006-06-11
AU2004262584A1 (en) 2005-02-17
CA2534709A1 (en) 2005-02-17
KR20060063933A (ko) 2006-06-12

Similar Documents

Publication Publication Date Title
ATE458009T1 (de) Polysaccharidderivate mit antithrombotischer wirkung im plasma
AU3926195A (en) Polysaccharides having a high iduronic acid content
WO2002023190A3 (en) Methods and products related to low molecular weight heparin
CY1112808T1 (el) Μειγματα ολιγοσακχαριτων προερχομενων απο την ηπαρινη, η παρασκευη τους και φαρμακευτικες συνθεσεις που τα περιεχουν
US20090105192A1 (en) Glycosaminoglycans derived from k5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
EP1358215B1 (en) Glycosaminoglycans derived from k5 polysaccharide having high antithrombin activity and process for their preparation
AU3026597A (en) Derivatives of k5 polysaccharide having high anticoagulant activity
WO2024130161A3 (en) Novel camptothecin derivatives and conjugates thereof
US8227449B2 (en) Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
JP5053512B2 (ja) 非常に大きい硫酸化度を持つk5多糖体のエピマー化誘導体
MY136769A (en) Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
US9346893B2 (en) Process for the preparation of highly O-sulfated, epimerized derivatives of K5 polysacchride and intermediates therein
WO2024059626A3 (en) Biopolymers for ophthalmic use
ZA202503561B (en) A derivative of tamarind seed polysaccharide and a preparation process thereof
WO2024030660A3 (en) Cholesterol-modified hyaluronic acids
WO2024233743A3 (en) Formulations of calycosin
CA3278356A1 (en) Hydrolysate compositions and methods for producing thereof
WO2024044761A3 (en) β-1,3-GALACTOSYLTRANSFERASES FOR USE IN THE BIOSYNTHESIS OF OLIGOSACCHARIDES
WO2023166284A8 (en) Enzymes and uses thereof
TH36619A (th) จุลชีพอาหารและกรรมวิธีสำหรับเตรียมกรดไฮยาลูโรนิค
TH16351B (th) จุลชีพอาหารและกรรมวิธีสำหรับเตรียมกรดไฮยาลูโรนิค

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee